Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lubna Ahmed

London, U.K
From Scrip website: Lubna Ahmed joined the Scrip editorial team in 2015 as a shiny new graduate in human biology and journalism, an interesting combination and perfect prologue to a career with Scrip. She is particularly interested in digital medicine and technology, social media, and who is moving where within the pharma industry. Lubna has a surprisingly large Twitter following for a non-celebrity, and when she isn't reading, writing or editing pharma-related news and analysis, she can be found eating chocolate and composing tweets to keep the Twittersphere entertained.
Advertisement
Set Alert for Articles By Lubna Ahmed

Latest From Lubna Ahmed

Appointments: Five Prime, Depomed, Gilead, Arix Bioscience and Corbus

This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.

Appointments BioPharmaceutical

Back To The Drawing Board For Double Bond's Temodex Mission

A failed deal has left Double Bond Pharmaceuticals again on the search for a partner in order to take its lead products forward. CEO Igor Lokot shares next steps and partnering plans.

Commercial Companies

Appointments: BMS, Scancell, Zafgen, Cell Medica, Silence Therapeutics, Malin and Trillium

This week's roundup includes CEO appointments by Gadeta, Scancell and Zafgen, with various other high-level appointments by Malin Corporation, Cell Medica and Apeiron Biologics.

Appointments BioPharmaceutical

Deal Watch: AbbVie Bets On Turnstone’s Cancer Immunotherapy Technology

AbbVie takes options on three oncolytic virus immunotherapies under development at Turnstone. Amgen and CytomX swap IP in cancer immunotherapy collaboration, while Nicox and pSivida will team to fight glaucoma and other eye diseases.

Deals Business Strategies

Appointments: CRISPR, KSQ Therapeutics, Immunocore, Cellectis, Translate Bio and biOasis

This week's roundup includes CEO appointments by CRISPR Therapeutics and KSQ Therapeutics, in addition to various other board and high-level appointments by Oncorus, Cellectis, BiOasis, Avillion and Revolution Medicines.

Appointments BioPharmaceutical

Appointments: Lilly, Kiadis, Pliant, Alma, NeuroVia and Nektar Therapeutics

This week's roundup includes a handful of promotions by Eli Lilly, and various board and high-level appointments by companies including Kiadis Pharma, Aeterna Zentaris, Dermavant Sciences and Pliant Therapeutics.

Appointments BioPharmaceutical
See All
Advertisement
UsernamePublicRestriction

Register